Urso 250 and Peg-intron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Urso 250 (ursodiol) and Peg-intron (peginterferon alfa-2b). Common drug interactions include anaemia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Urso 250 and Peg-intron. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Urso 250?

Urso 250 has active ingredients of ursodiol. eHealthMe is studying from 5,080 Urso 250 users. Check the latest studies of Urso 250.

What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users. Check the latest studies of Peg-intron.

On Jul, 26, 2026

56 people who take Urso 250 and Peg-intron together, and have interactions are studied.

Urso 250 and Peg-intron drug interactions.

What are the common drug interactions of Urso 250 and Peg-Intron, by gender? *:

female:

Anaemia (lack of blood)
Blood albumin decreased
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Face oedema (swelling of face)
Glomerulonephritis proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys)
Hiv test positive
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Blood pressure increased
Haematocrit decreased

male:

Anaemia (lack of blood)
Dizziness
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hepatic failure (liver failure)
Immune system disorder
Insomnia (sleeplessness)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Post procedural infection
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Skin ulcer

What are the common drug interactions of Urso 250 and Peg-Intron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Haemoglobin decreased
Platelet count decreased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Hiv test positive
Irritability
Liver disorder (liver diseases)
Acute hepatic failure
Affect lability (emotional incontinence)
Anaemia (lack of blood)

40-49:

Dizziness
Sick sinus syndrome (a collection of heart rhythm disorders)
Chorioretinitis (an inflammation of the choroid (thin pigmented vascular coat of the eye) and retina of the eye)
Post procedural infection
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Vogt-koyanagi-harada syndrome (disease of the eyes characterized by bilateral uveitis, alopecia, skin disease with depigmentation and hearing loss)
Colitis ulcerative (inflammation of colon with ulcer)
Conjunctival erosion (removal of conjunctiva)
Foreign body sensation in eyes (feeling of something in eye)
Haemoglobin decreased

50-59:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Anaemia (lack of blood)
Blood albumin decreased
Delirium (wild excitement)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
Parotid gland enlargement
Proteinuria (presence of protein in the urine)
Pyrexia (fever)

60+:

Anaemia (lack of blood)
Injection site cellulitis (injection site inflammation)
Haemoglobin decreased
Immune system disorder
Loss of consciousness
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Platelet count decreased
Renal cell carcinoma (a kidney cancer)
Renal cyst (kidney cyst)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

What are the existing conditions these people have? *

Hepatitis C: 55 people, 98.21%

* Approximation only. Some reports may have incomplete information.

Do you take Urso 250 and Peg-intron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously